The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
well I yeah that's different question is is chronic caloric restriction beneficial in normal weight people but most people taking gp1 agonists aren't normal yes and I think it's impossible at this point because the studies are all done in obese and type and patients with type 2 diabetes that we can't disentangle them so we will just say that for that patient population the caloric restriction appears to be gero protective
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so we will just say that for that patient population the caloric restriction appears to be geroprotective